相关实验视频

Updated: Jul 2, 2025

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

在固体器官移植中的非标签免疫抑制药物

Rita Nogueiras-Álvarez¹, María Del Mar García-Sáiz^2,3,4

¹Clinical Trials Unit, Bioaraba Health Research Institute, 01009 Vitoria-Gasteiz, Spain.

Pharmacy (Basel, Switzerland)

|February 23, 2024

概括

固体器官移植 (SOT) 需要免疫抑制剂,但许多器官缺乏具体的移植指示. 本次审查强调了各地区和患者群体在SOT药物批准方面的监管差异.

科学领域:

药理学药理学是指药理学的学科.
移植医学移植医学移植医学
监管科学监管科学

背景情况:

固体器官移植 (SOT) 需要终身免疫抑制,以防止移植物被拒绝.
许多免疫抑制药物在其技术数据表中缺乏FDA或EMA批准的用于移植的特定指示.
由于这些监管缺陷,在SOT中,非标签处方免疫抑制剂是常见的.

研究的目的:

在不同的固体器官移植模式中分析和比较免疫抑制药物的批准指示.
根据年龄组,配方和地理区域来识别批准指示的变化.
为医疗保健专业人员提供有关监管格局和非标签免疫抑制剂在SOT中的使用率的信息.

主要方法:

系统审查来自欧洲 (EMA) 和美国 (FDA) 监管机构的药物信息.
基于SOT类型的免疫抑制剂的批准指示的分析.
对不同人口和地区的指示差异的比较评估.

主要成果:

在不同类型的SOT之间,已批准的免疫抑制剂的适用性存在显著差异.
鉴于患者的年龄,药物配方和地理位置,观察到批准的适用症的变化.
监管部门的批准并不总是与临床共识或实践保持一致.

结论:

针对SOT的免疫抑制药物指示因监管机构和移植类型而异.
医疗保健专业人员必须意识到非标签处方现实和监管细微差别.
进一步协调或对SOT免疫抑制指示的明确指导是合理的.

关键词:

临床药理学临床药理学免疫抑制剂免疫抑制剂免疫抑制药物免疫抑制药物在标签之外的处方.实体器官移植移植实体器官移植

更多相关视频

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection

Published on: August 20, 2007

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...